Search

Your search keyword '"Staszewsky L."' showing total 166 results

Search Constraints

Start Over You searched for: Author "Staszewsky L." Remove constraint Author: "Staszewsky L."
166 results on '"Staszewsky L."'

Search Results

2. Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

4. ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016

6. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

9. Circulating levels and prognostic cut-offs of sST2, high-sensitivity troponin T, and NT-proBNP in women vs. men with chronic heart failure

10. Incretin-based drugs and hospitalization for heart failure in the clinical practice: A nested case-control study

11. Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

15. 3381Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes

18. Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure

19. Valsartan for prevention of recurrent atrial fibrillation

20. Valsartan for prevention of recurrent atrial

21. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension

22. Ranolazine ameliorates postresuscitation electrical instability and myocardial dysfunction and improves survival with good neurologic recovery in a rat model of cardiac arrest

23. Valsartan for prevention of recurrent atrial fibrillation (New England Journal of Medicine (2009) 360, (1606-1617))

26. Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

27. Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

28. Ibuprofen plus isosorbide dinitrate treatment in the mdx mice ameliorates dystrophic heart structure

29. Histone deacetylase inhibition enhances self renewal and cardioprotection by human cord blood-derived CD34 cells

30. Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency

31. Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle

32. Junctional adhesion molecule-A-deficient polyrnorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury

33. Eplerenone, a selective Aldosterone Blocker, improves diastolic Function in aged Rats with small-to-moderate myocardial Infarction

34. 1002-84 Eplerenone normalizes diastolic relaxation and extracellular matrix accumulation in aged rats with myocardial infarction

35. Sunday, 18 July 2010

36. Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency

37. Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle

40. n-3PUFA and Holter-derived autonomic variables in patients with heart failure: data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter substudy.

43. Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study.

44. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE Multicenter Trial

46. ESICM LIVES 2016: part three : Milan, Italy. 1-5 October 2016

47. GISSI-3 - EFFECTS OF LISINOPRIL AND TRANSDERMAL GLYCERYL TRINITRATE SINGLY AND TOGETHER ON 6-WEEK MORTALITY AND VENTRICULAR-FUNCTION AFTER ACUTE MYOCARDIAL-INFARCTION

48. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: The GISSI-3 trial

Catalog

Books, media, physical & digital resources